SAB Biotherapeutics
Price & Volume
Stats
See more52W Range | $1-$5.01 |
Market Cap | $24.3M |
Shares Short | 405,214 |
Financials
See moreRevenue (12 Mos) | $114,698 |
Revenue Growth (YoY) | -62.4% |
Gross Profit (12 Mos) | -$30M |
Diluted EPS | -$3.99 |
News
See moreYahoo Finance • 21 days ago
SAB BIO Highlights Data in Multiple Presentations at EASD
Yahoo Finance • last month
SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes
Yahoo Finance • last month
SAB Biotherapeutics files to sell 250M shares of common stock for holders
Yahoo Finance • 2 months ago
Chardan Capital lowers SAB Biotherapeutics stock price target to $12 from $20
About
CEO | Mr. Samuel J. Reich |
CFO | Ms. Lucy To |
Address | 777 W 41st St., Miami Beach, FL, United States, 33140 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 63 |
